Results 51 to 60 of about 201,919 (214)
The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
Introduction: Cannabidiol (CBD) is a widely utilized nonpsychoactive cannabinoid available as an over-the-counter supplement, a component of medical cannabis, and a prescriptive treatment of childhood epilepsies.
John S. Markowitz +6 more
doaj +1 more source
Pharmacotherapy for Obesity [PDF]
Obesity is an important risk factor for metabolic disease and various cancers. Treatments of obesity include lifestyle intervention, pharmacotherapy, and bariatric surgery. If weight loss with lifestyle intervention is only modest, pharmacotherapy might be needed.
Joo, Jong Kil, Lee, Kyu Sup
openaire +2 more sources
Background Prior studies reported that exposure to antidepressants during pregnancy may be associated with gestational hypertension. The aim of this study is to assess the association between the use of antidepressants during pregnancy and the risk of ...
Neily Zakiyah +5 more
doaj +1 more source
Objectives: The clinical usefulness of tumor markers alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP) in the early detection of hepatocellular carcinoma (HCC) in patients with liver cirrhosis (LC), including those with marker decline after ...
Maiko Machida PhD +7 more
doaj +1 more source
Pharmacotherapy of Asthma [PDF]
The pharmacotherapy of asthma is a complex and evolving topic. A detailed understanding of the pathophysiologic processes involved in the asthmatic response forms the basis for understanding the actions of drugs used to treat this condition. Likewise, a solid comprehension of the medicinal chemistry and pharmacologic properties of the numerous agents ...
openaire +2 more sources
Pharmacotherapy for Eating Disorders
This chapter addresses the pharmacotherapy of the eating disorders (EDs). Many persons with EDs receive pharmacotherapy, but pharmacotherapy research for EDs has lagged behind that for other major mental disorders.
Nicole Mori +3 more
core +1 more source
This review article summarizes the main treatments for chronic obstructive pulmonary disease, their mechanisms, and the key evidence from trials supporting their use. Drug classes covered were short acting beta agonists (SABA), short acting muscarinic antagonists (SAMA), long acting beta agonists (LABA), long acting antimuscarinics (LAMA), inhaled ...
Stan Ejiofor, Alice M. Turner
openaire +4 more sources
Background Cannabidiol (CBD), main non-psychoactive ingredient of Cannabis sativa L. is known to have anti-ischemic, antidiabetic and neuroprotective effects.
Barbara Takács +11 more
doaj +1 more source
Background Cardiac remodelling, a crucial aspect of heart failure, is commonly investigated in preclinical models by quantifying cardiomyocyte cross‐sectional area (CSA) and microvascular density (MVD) via histological methods, such as ...
Tamás G. Gergely +14 more
doaj +1 more source

